Nationwide Fund Advisors’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-6,999
| Closed | -$39K | – | 3419 |
|
|
2016
Q1 | $39K | Buy |
6,999
+344
| +5% | +$1.92K | ﹤0.01% | 3030 |
|
|
2015
Q4 | $114K | Hold |
6,655
| – | – | ﹤0.01% | 2797 |
|
|
2015
Q3 | $140K | Hold |
6,655
| – | – | ﹤0.01% | 2757 |
|
|
2015
Q2 | $329K | Sell |
6,655
-2,332
| -26% | -$115K | ﹤0.01% | 2469 |
|
|
2015
Q1 | $704K | Sell |
8,987
-326
| -4% | -$25.5K | ﹤0.01% | 2079 |
|
|
2014
Q4 | $564K | Sell |
9,313
-3,616
| -28% | -$219K | ﹤0.01% | 2114 |
|
|
2014
Q3 | $551K | Buy |
12,929
+501
| +4% | +$21.4K | ﹤0.01% | 2158 |
|
|
2014
Q2 | $768K | Buy |
12,428
+777
| +7% | +$48K | ﹤0.01% | 2031 |
|
|
2014
Q1 | $757K | Buy |
11,651
+1,831
| +19% | +$119K | ﹤0.01% | 1869 |
|
|
2013
Q4 | $553K | Buy |
9,820
+2,277
| +30% | +$128K | ﹤0.01% | 2198 |
|
|
2013
Q3 | $463K | Sell |
7,543
-2,851
| -27% | -$175K | ﹤0.01% | 2263 |
|
|
2013
Q2 | $608K | Buy |
+10,394
| New | +$608K | ﹤0.01% | 1932 |
|